CAREDX, INC. Amortization
CAREDX, INC. (CDNA) reported Amortization of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2024-02-28
- CAREDX, INC. amortization for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CAREDX, INC. amortization for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
- CAREDX, INC. amortization for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
- CAREDX, INC. amortization for fiscal 2020 was $100.00K, a 50.00% decline from fiscal 2019.
| Period end | Amortization 12 month | Amortization 12 month as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2022-12-31 | $100.00K 10-K · filed 2024-02-28 | |
| 2021-12-31 | $100.00K 10-K · filed 2024-02-28 | |
| 2020-12-31 | $100.00K 10-K · filed 2023-02-27 | |
| 2019-12-31 | $200.00K 10-K · filed 2022-02-24 | |
| 2018-12-31 | $200.00K 10-K · filed 2021-02-24 | $153.05K 10-K · filed 2019-03-06 |
| 2017-12-31 | $100.00K 10-K · filed 2020-02-28 | $135.00K 10-K · filed 2018-03-22 |
| 2016-12-31 | $204.00K 10-K · filed 2019-03-06 | |
| 2015-12-31 | $79.00K 10-K · filed 2018-03-22 | |
| 2014-12-31 | $59.00K 10-K · filed 2017-04-21 | |
| 2013-12-31 | $26.00K 10-K · filed 2016-03-29 | |
| 2012-12-31 | $70.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |